Are We There Yet? How and When Specific Biotechnologies Will Improve Human Health

Elizabeth O'Day, Leticia Hosta-Rigau, Diego A. Oyarzún, Hideyuki Okano, Víctor de Lorenzo, Conrad von Kameke, Habiba Alsafar, Cong Cao, Guo Qiang Chen, Weizhi Ji, Richard J. Roberts, Mostafa Ronaghi, Karen Yeung, Feng Zhang, Sang Yup Lee

研究成果: Review article査読

6 被引用数 (Scopus)

抄録

Patient X: A 67-year-old Caucasian man slips on a patch of ice. He has abrasions to his hands and has sustained significant damage to his hip. At the emergency room, he informs clinicians he takes atorvastatin, metformin, and glimepiride to treat hypertension and Type 2 Diabetes Mellitus (T2DM). X-rays reveal a fractured hip, which will require total hip replacement surgery.

本文言語English
論文番号1800195
ジャーナルBiotechnology Journal
14
1
DOI
出版ステータスPublished - 2019 1

ASJC Scopus subject areas

  • Applied Microbiology and Biotechnology
  • Molecular Medicine

フィンガープリント 「Are We There Yet? How and When Specific Biotechnologies Will Improve Human Health」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル